Cooley’s global mergers and acquisitions and private equity practices were again recognized for top ranking positions in Q3 league tables from Bloomberg.* Despite the unpredictable market, Cooley continues to dominate in public and private deals around the world.
Top rankings by deal count include:
- #1 for US and global life sciences M&A
- #1 for US and global tech M&A
- #3 for US and global M&A
- #3 for US and global mid-market M&A
- #3 US private equity deals
- #4 global private equity deals
In 2026, Cooley handled transactions across a diverse range of industries while also maintaining its top position in technology and life sciences. The firm’s market-leading transactions include representing:
- OpenZeppelin in its acquisition by S&P Global
- Yardi in its acquisition of Sidero Labs
- Chimagen Biosciences in its agreement to sell asset to GSK for up to $750 million
- Virtue AI in its acquisition by Fortinet
- Ambros Therapeutics in its $550 million merger with Werewolf Therapeutics and concurrent $150 million private financing
- Lynk Global in its merger with Omnispace, concurrent investments and partnerships with SES and Nelco
- Slate Medicines in its merger with Fulcrum Therapeutics
- Redx Pharma in its acquisition by Skye Bioscience and concurrent $125 million in financings
- Actio Biosciences in its acquisition by Jazz Pharmaceuticals for up to $1.32 billion
- AlixPartners in its acquisition of Artium
- Professional Fighters League in its merger with Most Valuable Promotions
- Procore Technologies in its acquisition of DroneDeploy for approximately $845 million
- Canoe Intelligence in its acquisition by Bloomberg
- Vidya Therapeutics in its sale to Processa Pharmaceuticals
- Research Alliance Corporation III in its combination with Oak Hill Bio
- Copra in its acquisition by The Vita Coco Company
- Scancell in its acquisition of Neuphoria and concurrent $89 million private financing
- Keyrock in its acquisition of BlockFills’ trading and brokerage assets
- Personalis in its acquisition by Tempus AI for $1.9 billion
Since 2021, Cooley’s world-class transactional team has worked on 1,600+ M&A deals for an aggregate value of more than $750 billion – guiding top public and private companies, financial advisors and private equity sponsors in some of the market’s largest and most complex transactions. The M&A and PE groups include 180+ practitioners in major business and technology centers worldwide, representing all categories of participants in transactions.
* The Bloomberg platform data has not been published by Bloomberg.
Topics: